Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
6095.T Stock Summary
In the News
6095.T Financial details
Company Rating
Strong Buy
Market Cap
15.9B
Income
637.02M
Revenue
15.01B
Book val./share
391.31
Cash/share
229.45
Dividend
4.5
Dividend %
0.62%
Employees
611
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
25.66
Forward P/E
21.72
PEG
-11.67
P/S
1.08
P/B
1.91
P/C
3.02
P/FCF
-
Quick Ratio
3.59
Current Ratio
3.74
Debt / Equity
0.43
LT Debt / Equity
0.35
-
-
EPS (TTM)
29.35
EPS next Y
31.9
EPS next Q
-
EPS this Y
-24.69%
EPS next Y
8.69%
EPS next 5Y
72.4%
EPS last 5Y
6.13%
Revenue last 5Y
36.71%
Revenue Q/Q
7.63%
EPS Q/Q
38.59%
-
-
-
-
SMA20
-9.82%
SMA50
-0.28%
SMA100
-22.59%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
8%
ROC
0.09%
Gross Margin
47%
Oper. Margin
8%
Profit Margin
4%
Payout
-
Shs Outstand
21.72M
Shs Float
12.44M
-
-
-
-
Target Price
-
52W Range
661.0-1192.0
52W High
-41.86%
52W Low
+4.84%
RSI
41
Rel Volume
0.51
Avg Volume
272.63K
Volume
139.1K
Perf Week
-4.68%
Perf Month
2.97%
Perf Quarter
-31.52%
Perf Half Y
-31.32%
-
-
-
-
Beta
1.199
-
-
Volatility
15.43%, 34.49%
Prev Close
-1.28%
Price
693
Change
-2.12%
6095.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
Metric | History | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 153.28 | 239.33 | 323.47 | 391.44 | 666.88 | |
Net income per share | 19.87 | 32.71 | 56.27 | 37.62 | 28.33 | |
Operating cash flow per share | 18.84 | 41.92 | 59.23 | 39.51 | 27.52 | |
Free cash flow per share | 13.17 | 34.2 | 48.44 | 32 | 22.66 | |
Cash per share | 157.49 | 212.03 | 248.03 | 284.3 | 247.34 | |
Book value per share | 164.15 | 241.19 | 291.8 | 351.62 | 380.46 | |
Tangible book value per share | 165.16 | 231.29 | 282.79 | 331.75 | 173.02 | |
Share holders equity per share | 164.15 | 241.19 | 291.8 | 351.62 | 380.46 | |
Interest debt per share | 7.73 | 9.23 | 6.01 | 8.35 | 175.31 | |
Market cap | 23.15B | 108.3B | 88.27B | 27.92B | 22.22B | |
Enterprise value | 20.17B | 103.79B | 82.7B | 21.96B | 20.63B | |
P/E ratio | 58.62 | 149.17 | 68.24 | 34.37 | 35.97 | |
Price to sales ratio | 7.6 | 20.39 | 11.87 | 3.3 | 1.53 | |
POCF ratio | 61.83 | 116.41 | 64.83 | 32.72 | 37.03 | |
PFCF ratio | 88.47 | 142.71 | 79.27 | 40.4 | 44.97 | |
P/B Ratio | 7.1 | 20.23 | 13.16 | 3.68 | 2.68 | |
PTB ratio | 7.1 | 20.23 | 13.16 | 3.68 | 2.68 | |
EV to sales | 6.62 | 19.54 | 11.12 | 2.6 | 1.42 | |
Enterprise value over EBITDA | 31.71 | 81.54 | 41.52 | 16.88 | 10.37 | |
EV to operating cash flow | 53.88 | 111.57 | 60.75 | 25.74 | 34.39 | |
EV to free cash flow | 77.09 | 136.78 | 74.28 | 31.78 | 41.76 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.03 | 0.03 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Debt to equity | 0.05 | 0.04 | 0.02 | 0.02 | 0.46 | |
Debt to assets | 0.04 | 0.03 | 0.02 | 0.02 | 0.25 | |
Net debt to EBITDA | -4.68 | -3.54 | -2.79 | -4.58 | -0.8 | |
Current ratio | 7.37 | 4.67 | 5.42 | 6.02 | 3.74 | |
Interest coverage | 466.14 | 604.44 | 941.38 | 978.58 | 84.03 | |
Income quality | 0.67 | 0.82 | 0.75 | 0.77 | 0.57 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.19 | |
Payout ratio | 0 | 0 | 0 | 0 | 6.88 | |
Sales general and administrative to revenue | 0.02 | 0.04 | 0.03 | 0.03 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.03 | 0.06 | 0.06 | 0.07 | 0.32 | |
Capex to operating cash flow | -0.3 | -0.18 | -0.18 | -0.19 | -0.18 | |
Capex to revenue | -0.04 | -0.03 | -0.03 | -0.02 | -0.01 | |
Capex to depreciation | -1.41 | -1.22 | -1.47 | -0.87 | -0.13 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 270.92 | 421.35 | 607.82 | 545.58 | 492.44 | |
ROIC | 0.13 | 0.14 | 0.19 | 0.1 | 0.06 | |
Return on tangible assets | 0.1 | 0.11 | 0.16 | 0.09 | 0.06 | |
Graham Net | 146.49 | 186.78 | 225.46 | 262.56 | 64.25 | |
Working capital | 3.17B | 4.8B | 5.91B | 6.43B | 6.73B | |
Tangible asset value | 3.28B | 5.13B | 6.5B | 7.16B | 3.77B | |
Net current asset value | 3.07B | 4.56B | 5.69B | 6.22B | 2.61B | |
Invested capital | 0.05 | 0.04 | 0.02 | 0.02 | 0.46 | |
Average receivables | 480.58M | 896.41M | 1.3B | 1.32B | 2.38B | |
Average payables | 7.08M | 28.99M | 68.91M | 82.79M | 69.31M | |
Average inventory | 7.97M | 17.45M | 79.36M | 77.29M | 25.42M | |
Days sales outstanding | 60.23 | 88.67 | 63.93 | 57.77 | 86.09 | |
Days payables outstanding | 2.89 | 10.24 | 12.33 | 8.37 | 2.86 | |
Days of inventory on hand | 0.12 | 7 | 17.55 | 3.25 | 0.97 | |
Receivables turnover | 6.06 | 4.12 | 5.71 | 6.32 | 4.24 | |
Payables turnover | 126.08 | 35.66 | 29.6 | 43.61 | 127.42 | |
Inventory turnover | 3.1K | 52.15 | 20.79 | 112.19 | 376.61 | |
ROE | 0.12 | 0.14 | 0.19 | 0.11 | 0.07 | |
Capex per share | -5.67 | -7.73 | -10.79 | -7.51 | -4.86 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q1
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 169.31 | 157.19 | 162.56 | 177.88 | 191.46 | |
Net income per share | 12.42 | 5.03 | 1.29 | 9.64 | 13.36 | |
Operating cash flow per share | 15.85 | 16.5 | 16.63 | 25.5 | 14.17 | |
Free cash flow per share | 15.85 | 16.5 | 16.63 | 25.5 | 14.17 | |
Cash per share | 250.97 | 260.63 | 247.66 | 248.67 | 229.45 | |
Book value per share | 375.5 | 381.65 | 369.87 | 382.5 | 391.31 | |
Tangible book value per share | 180.97 | 196.33 | 190.58 | 173.95 | 188.78 | |
Share holders equity per share | 375.5 | 381.65 | 369.87 | 382.5 | 391.31 | |
Interest debt per share | 195.36 | 186.71 | 180.33 | 175.78 | 169.27 | |
Market cap | 29.94B | 24.13B | 22.04B | 22.1B | 15.53B | |
Enterprise value | 28.72B | 22.51B | 20.56B | 20.52B | 14.22B | |
P/E ratio | 27.68 | 54.82 | 195.05 | 26.43 | 13.4 | |
Price to sales ratio | 8.12 | 7.01 | 6.2 | 5.73 | 3.74 | |
POCF ratio | 86.77 | 66.78 | 60.63 | 39.96 | 50.54 | |
PFCF ratio | 86.77 | 66.78 | 60.63 | 39.96 | 50.54 | |
P/B Ratio | 3.66 | 2.89 | 2.73 | 2.66 | 1.83 | |
PTB ratio | 3.66 | 2.89 | 2.73 | 2.66 | 1.83 | |
EV to sales | 7.79 | 6.54 | 5.79 | 5.32 | 3.42 | |
Enterprise value over EBITDA | 60.09 | 85.31 | 168.37 | 65.44 | 29.02 | |
EV to operating cash flow | 83.25 | 62.29 | 56.57 | 37.1 | 46.28 | |
EV to free cash flow | 83.25 | 62.29 | 56.57 | 37.1 | 46.28 | |
Earnings yield | 0.01 | 0 | 0 | 0.01 | 0.02 | |
Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | |
Debt to equity | 0.52 | 0.49 | 0.49 | 0.46 | 0.43 | |
Debt to assets | 0.29 | 0.28 | 0.28 | 0.25 | 0.24 | |
Net debt to EBITDA | -2.54 | -6.15 | -12.08 | -5.05 | -2.67 | |
Current ratio | 4.05 | 4.13 | 4.02 | 3.74 | 4.13 | |
Interest coverage | 135.1 | 73.73 | 32.33 | 93.84 | 158.73 | |
Income quality | 1.28 | 3.29 | 12.98 | 2.65 | 1.06 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.31 | 0.3 | 0.3 | 0.32 | 0.31 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 323.89 | 207.73 | 103.69 | 288 | 342.93 | |
ROIC | 0.02 | 0.01 | 0 | 0.03 | 0.02 | |
Return on tangible assets | 0.03 | 0.01 | 0 | 0.02 | 0.03 | |
Graham Net | 82.7 | 96.46 | 91.01 | 64.59 | 78.15 | |
Working capital | 6.67B | 6.82B | 6.55B | 6.73B | 6.98B | |
Tangible asset value | 3.94B | 4.3B | 4.17B | 3.77B | 4.09B | |
Net current asset value | 2.87B | 3.16B | 3.03B | 2.61B | 3.01B | |
Invested capital | 0.52 | 0.49 | 0.49 | 0.46 | 0.43 | |
Average receivables | 2.21B | 3.03B | 2.99B | 3.21B | 3.65B | |
Average payables | 101.07M | 111.42M | 104.27M | 84.84M | 88.64M | |
Average inventory | 31.37M | 28.6M | 26.34M | 24.07M | 21.85M | |
Days sales outstanding | 75.22 | 77.79 | 75.93 | 80.01 | 83.88 | |
Days payables outstanding | 6.19 | 4.94 | 5.02 | 2.57 | 4.79 | |
Days of inventory on hand | 1.62 | 1.24 | 1.27 | 0.87 | 0.95 | |
Receivables turnover | 1.2 | 1.16 | 1.19 | 1.12 | 1.07 | |
Payables turnover | 14.53 | 18.22 | 17.91 | 35.04 | 18.81 | |
Inventory turnover | 55.72 | 72.43 | 70.62 | 103.56 | 94.39 | |
ROE | 0.03 | 0.01 | 0 | 0.03 | 0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
6095.T Frequently Asked Questions
What is MedPeer,Inc. stock symbol ?
MedPeer,Inc. is a JP stock and trading under the symbol 6095.T
What is MedPeer,Inc. stock quote today ?
MedPeer,Inc. stock price is $693 today.
Is MedPeer,Inc. stock public?
Yes, MedPeer,Inc. is a publicly traded company.